Precision Optics Corporation, Inc. revenue by segment POCI

Precision Optics Corporation, Inc. splits its revenue into 7 lines in its filings. The largest line in fiscal 2026, which ended Jun 30, 2026 was Systems Manufacturing at $22.6 million, 72% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
FY 2025
Jun 30, 2025
FY 2024
Jun 30, 2024
FY 2023
Jun 30, 2023
FY 2022
Jun 30, 2022
FY 2021
Jun 30, 2021
FY 2020
Jun 30, 2020
FY 2019
Jun 30, 2019
FY 2018
Jun 30, 2018
FY 2017
Jun 30, 2017
Revenue
32
19
19
21
16
11
10
7
4
3
Systems Manufacturing
23
+172.9%
share 71.8%
8
share 43.4%
—
—
—
—
—
—
—
—
Optical Components
—
—
8
share 43.9%
—
6
+12.7%
share 41.3%
6
share 53.9%
—
—
—
—
Ross Optical Industries
5
+31.7%
share 15.6%
4
share 19.5%
—
—
—
—
—
—
—
—
Medical Device
—
—
—
—
4
+77.6%
share 24.4%
2
share 20.2%
—
—
—
—
Engineering Design Services
3
-29.7%
share 11.0%
5
-40.7%
share 25.9%
8
+23.7%
share 43.6%
7
+25.3%
share 32.0%
5
+93.9%
share 34.3%
3
share 26.0%
—
—
—
—
Medical Device Products And Assemblies
—
—
2
-36.8%
share 12.5%
4
share 18.0%
—
—
—
—
—
—
Micro Optics Lab
1
-75.7%
share 1.6%
2
share 11.2%
—
—
—
—
—
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. More on our methodology.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
POCI (Nasdaq)
Fiscal year ends
June 30
Incorporated in
MA
Headquarters
Littleton, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
867840
Former names
PRECISION OPTICS Corp INC (until Jul 16, 2014); PRECISION OPTICS CORPORATION INC (until Oct 25, 2011)

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.